News
02-17-2017, 02:14 AM
Women with early-stage breast cancer who had an intermediate risk recurrence score (RS) from a 21-gene expression assay had similar outcomes, regardless of whether they received chemotherapy, a new...
More... (http://www.medicalnewstoday.com/releases/315903.php)
More... (http://www.medicalnewstoday.com/releases/315903.php)